Struthers Richard Scott
Director, Officer at CRNX
- Sold, on record
- $23.2M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Mar 16, 2026
- Form 144 notices
- 11
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CRNXCrinetics Pharmaceuticals, Inc.Director, Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CRNXRoutineMay 8, 2024 2024
Sold 107,448 shares at $49.40 ($5.3M)
Struthers Richard Scott, President & CEO
10b5-1 planSold 29.4% of holdings ($18M position)257,485 shares left2.1x usual sizeFollows a Form 144Filing
- 2 Form 144 notice CRNXNoticeDec 2, 2024 +208 days
Filed to sell 10,000 shares ($573k)
Struthers Richard Scott, Officer
10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale CRNXRoutineDec 2, 2024 same day
Sold 10,000 shares at $57.57 ($576k)
Struthers Richard Scott, President & CEO
10b5-1 planSold 9.1% of holdings ($6.3M position)100,000 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale CRNXRoutineMar 19, 2025 +107 days
Sold 17,338 shares at $34.20 ($593k)
Struthers Richard Scott, President & CEO
10b5-1 planSold 5% of holdings ($11.9M position)329,147 shares left0.3x usual sizeFiling
- 5 Form 144 notice CRNXNoticeSep 26, 2025 +191 days
Filed to sell 4,000 shares ($180k)
Struthers Richard Scott, Officer, Director
10b5-1 plan0.1x usual sizeFiling
- 6 Form 4 sale CRNXRoutineSep 26, 2025 same day
Sold 4,000 shares at $45.00 ($180k)
Struthers Richard Scott, President & CEO
10b5-1 planSold 3.6% of holdings ($5M position)106,000 shares left0.1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice CRNXNoticeMar 16, 2026 +171 days
Filed to sell 45,013 shares ($1.7M)
Struthers Richard Scott, Director, Officer
No 10b5-1 plan2.6x usual sizeFiling
- 8 Form 4 sale CRNXRoutineMar 16, 2026 same day
Sold 21,981 shares at $37.37 ($822k)
Struthers Richard Scott, President & CEO
10b5-1 planSold 5.2% of holdings ($15.9M position)404,778 shares left1.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 18, 2026 | CRNX | President & CEO | Form 4 sale | 21,981 | $822k | 5.2% | Routine | SEC |
| Mar 16, 2026 | Mar 16, 2026 | CRNX | Director, Officer | Form 144 notice | 45,013 | $1.7M | Notice | SEC | |
| Sep 26, 2025 | Sep 30, 2025 | CRNX | President & CEO | Form 4 sale | 4,000 | $180k | 3.6% | Routine | SEC |
| Sep 26, 2025 | Sep 26, 2025 | CRNX | Officer, Director | Form 144 notice | 4,000 | $180k | Notice | SEC | |
| Mar 19, 2025 | Mar 21, 2025 | CRNX | President & CEO | Form 4 sale | 17,338 | $593k | 5.0% | Routine | SEC |
| Dec 2, 2024 | Dec 4, 2024 | CRNX | President & CEO | Form 4 sale | 10,000 | $576k | 9.1% | Routine | SEC |
| Dec 2, 2024 | Dec 2, 2024 | CRNX | Officer | Form 144 notice | 10,000 | $573k | Notice | SEC | |
| May 8, 2024 | May 10, 2024 | CRNX | President & CEO | Form 4 sale | 107,448 | $5.3M | 29.4% | Routine | SEC |
| May 8, 2024 | May 8, 2024 | CRNX | Officer, Director | Form 144 notice | 107,448 | $5.3M | Notice | SEC | |
| Apr 4, 2024 | Apr 8, 2024 | CRNX | President & CEO | Form 4 sale | 40,951 | $2M | 14.7% | Routine | SEC |
| Apr 4, 2024 | Apr 4, 2024 | CRNX | Officer, Director | Form 144 notice | 40,951 | $2M | Notice | SEC | |
| Nov 3, 2023 | Nov 6, 2023 | CRNX | President & CEO | Form 4 sale | 200,000 | $6.1M | 59.6% | Unusual | SEC |
| Nov 3, 2023 | Nov 3, 2023 | CRNX | Officer | Form 144 notice | 199,082 | $6M | Notice | SEC | |
| Nov 2, 2023 | Nov 2, 2023 | CRNX | Officer | Form 144 notice | 918 | $27k | Notice | SEC | |
| Jul 13, 2023 | Jul 13, 2023 | CRNX | President & CEO | Form 4 sale | 50,000 | $1M | 7.3% | Routine | SEC |
| Jul 13, 2023 | Jul 13, 2023 | CRNX | Officer | Form 144 notice | 14,157 | $288k | Notice | SEC | |
| Jul 12, 2023 | Jul 12, 2023 | CRNX | Officer | Form 144 notice | 11,459 | $231k | Notice | SEC | |
| Jul 11, 2023 | Jul 11, 2023 | CRNX | Officer, CEO | Form 144 notice | 24,384 | $491k | Notice | SEC | |
| Jun 16, 2023 | Jun 21, 2023 | CRNX | President & CEO | Form 4 sale | 50,000 | $1M | 6.8% | Routine | SEC |
| Jun 16, 2023 | Jun 16, 2023 | CRNX | Officer | Form 144 notice | 50,000 | $1M | Notice | SEC | |
| Apr 13, 2022 | Apr 15, 2022 | CRNX | President & CEO | Form 4 sale | 138,643 | $3.7M | 15.9% | Unusual | SEC |
| Apr 5, 2022 | Apr 7, 2022 | CRNX | President & CEO | Form 4 sale | 21,357 | $541k | 2.4% | Plan not stated | SEC |
| Sep 7, 2021 | Sep 9, 2021 | CRNX | President & CEO | Form 4 sale | 30,000 | $750k | 25.0% | Unusual | SEC |
| Jul 16, 2020 | Jul 17, 2020 | CRNX | President & CEO | Form 4 sale | 35,000 | $521k | 3.8% | Plan not stated | SEC |